
Darren Smyth, Richard Croker, and Ben Goldacre explain the arguments over the patent case and explore the wider implications for the NHS and drug development
07 June 2018
Smyth, D., Croker, R., & Goldacre, B. (2018). Pregabalin. BMJ, k2318.
Darren Smyth, Richard Croker, and Ben Goldacre explain the arguments over the patent case and explore the wider implications for the NHS and drug development
Read the full paper at bmj.com
Radcliffe Primary Care Building
Radcliffe Observatory Quarter
Woodstock Rd
Oxford
OX2 6GG
© University of Oxford for the DataLab 2021. This work may be copied freely for non-commercial research and study. If you wish to do any of the other acts restricted by the copyright you should apply in writing to [email protected].